Literature DB >> 18187544

Cysteine-rich protein 61 and connective tissue growth factor induce deadhesion and anoikis of retinal pericytes.

Haibo Liu1, Ru Yang, Babben Tinner, Annam Choudhry, Norbert Schutze, Brahim Chaqour.   

Abstract

Loss of retinal pericytes is one of the distinctive features of diabetic retinopathy (DR), which is characterized by retinal capillary obliteration. The matricellular proteins, cysteine-rich protein 61 (Cyr61) and connective tissue growth factor (CTGF), are aberrantly expressed in the retinal vasculature from the early stages of DR, but their effects on retinal pericytes are unknown. We show herein that rat retinal pericytes (RRPs) exposed to advanced glycosylation-end products, an important injurious stimulus of diabetes, express increased levels of both Cyr61 and CTGF, and concomitantly undergo anoikis, a form of apoptosis by loss of cell-matrix interactions. Adenovirus-mediated expression of Cyr61 and/or CTGF conferred an anoikis-prone phenotype to rat retinal pericytes, including decreased phosphotyrosine protein levels at focal adhesion points and formation of cortical actin rings. When used as substrates for pericyte attachment and compared with other matrix proteins (e.g. type IV collagen), recombinant Cyr61 and CTGF proteins exhibited antiadhesive and apoptogenic activities. Phosphatase inhibitors reversed these effects, suggesting that Cyr61 and CTGF promote dephosphorylation events. Furthermore, Cyr61- and CTGF-induced apoptosis was mediated through the intrinsic pathway and involved the expression of genes that have been functionally grouped as p53 target genes. Expression of the matrix metalloproteinase-2 gene, a known target of p53, was increased in pericytes overexpressing either Cyr61 or CTGF. Inhibition of matrix metalloproteinase-2 had, at least in part, a protective effect against Cyr61- and CTGF-induced apoptosis. Taken together, these findings support the involvement of Cyr61 and CTGF in pericyte detachment and anoikis, implicating these proteins in the pathogenesis of DR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18187544     DOI: 10.1210/en.2007-1415

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  31 in total

1.  Cysteine-rich 61 (CYR61) is up-regulated in proliferative diabetic retinopathy.

Authors:  Xiao Zhang; Weihong Yu; Fangtian Dong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-13       Impact factor: 3.117

2.  Extracellular matrix associated protein CYR61 is linked to prostate cancer development.

Authors:  Katherine B D'Antonio; Antoun Toubaji; Roula Albadine; Alison M Mondul; Elizabeth A Platz; George J Netto; Robert H Getzenberg
Journal:  J Urol       Date:  2010-02-20       Impact factor: 7.450

Review 3.  Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy.

Authors:  A Guzman-Aranguez; P Loma; J Pintor
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

4.  The matricellular protein CCN1 controls retinal angiogenesis by targeting VEGF, Src homology 2 domain phosphatase-1 and Notch signaling.

Authors:  Hemabindu Chintala; Izabela Krupska; Lulu Yan; Lester Lau; Maria Grant; Brahim Chaqour
Journal:  Development       Date:  2015-05-22       Impact factor: 6.868

5.  TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3.

Authors:  Rachel A Hesler; Jennifer J Huang; Mark D Starr; Victoria M Treboschi; Alyssa G Bernanke; Andrew B Nixon; Shannon J McCall; Rebekah R White; Gerard C Blobe
Journal:  Carcinogenesis       Date:  2016-11-01       Impact factor: 4.944

6.  Mechanical strain activates a program of genes functionally involved in paracrine signaling of angiogenesis.

Authors:  Ru Yang; Jawaria Amir; Haibo Liu; Brahim Chaqour
Journal:  Physiol Genomics       Date:  2008-10-14       Impact factor: 3.107

7.  Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?

Authors:  Roger M Mason
Journal:  J Cell Commun Signal       Date:  2009-02-14       Impact factor: 5.782

8.  Paracrine control of oligodendrocyte differentiation by SRF-directed neuronal gene expression.

Authors:  Christine Stritt; Sina Stern; Kai Harting; Thomas Manke; Daniela Sinske; Heinz Schwarz; Martin Vingron; Alfred Nordheim; Bernd Knöll
Journal:  Nat Neurosci       Date:  2009-03-08       Impact factor: 24.884

9.  Connective tissue growth factor regulates retinal neovascularization through p53 protein-dependent transactivation of the matrix metalloproteinase (MMP)-2 gene.

Authors:  Hembindu Chintala; Haibo Liu; Rahul Parmar; Monika Kamalska; Yoon Ji Kim; David Lovett; Maria B Grant; Brahim Chaqour
Journal:  J Biol Chem       Date:  2012-10-09       Impact factor: 5.157

10.  Molecular control of vascular development by the matricellular proteins CCN1 (Cyr61) and CCN2 (CTGF).

Authors:  Brahim Chaqour
Journal:  Trends Dev Biol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.